← FDA DRUG APPROVALS

FDA ANDA · ANDA076422

CICLOPIROX

Sponsor: FOUGERA PHARMS

APPLICATION
ANDA076422
TYPE
ANDA
ORIGINAL APPROVAL
2004-08-06
LATEST ACTION
2006-01-11
ROUTE
TOPICAL
DOSAGE FORM
SUSPENSION
MARKETING STATUS
Prescription

Products

CICLOPIROXPrescription
CICLOPIROX 0.77% · SUSPENSION · TOPICAL

Approval history

2006-01-11Labeling · Supplement 4AP
2004-08-06OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →